Findings gathered over decades of research, combined with substantial government funding and unprecedented collaboration across the biopharmaceutical industry, enabled the success of mRNA vaccines to combat COVID-19. mRNA is a highly promising technology — the market for which is expected to grow steadily in coming years — but it has many unexplored elements requiring additional study. In this Q&A, learn Samsung Biologics' key insights on the current mRNA market trends and what to consider for a successful launch of your development.
Findings gathered over decades of research, combined with substantial government funding and unprecedented collaboration across the biopharmaceutical industry, enabled the success of mRNA vaccines to combat COVID-19. mRNA is a highly promising technology — the market for which is expected to grow steadily in coming years — but it has many unexplored elements requiring additional study. In this Q&A, learn Samsung Biologics' key insights on the current mRNA market trends and what to consider for a successful launch of your development.
- CDO
- CGMP
- ADC
- Bio Campus
- IR
- CMO